Titles
- Temporary policy for preparation of certain alcohol-based hand sanitizer products during the public health emergency (COVID-19)2
- Temporary policy on Prescription Drug Marketing Act requirements for distribution of drug samples during the COVID-19 public health emergency1
- Temporary policy on repackaging or combining propofol drug products during the COVID-19 public health emergency1
- Temporary policy regarding accredited third-party certification program onsite observation and certificate duration requirements during the COVID-19 public health emergency1
- Temporary policy regarding non-standard PPE practices for sterile compounding by pharmacy compounders not registered as outsourcing facilities during the COVID-19 public health emergency1
- Temporary policy regarding preventive controls and FSVP food supplier verification onsite audit requirements during the COVID-19 public health emergency: guidance for industry1
- Ten years of the Affordable Care Act: major gains and ongoing disparities1
- Testing and labeling medical devices for safety in the magnetic resonance (MR) environment: guidance for industry and Food and Drug Administration staff1
- Testing for biotin interference in in vitro diagnostic devices1
- Testing of retroviral vector-based human gene therapy products for replication competent retrovirus during product manufacture and patient follow-up1
- Texas: Latino children's health coverage facts1
- Tezepelumab for severe asthma: final report1
- The "deemed to be a license" provision of the BPCI Act: questions and answers1
- The 2021 CHCF California Health Policy Survey1
- The Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program: guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff1
- The American Rescue Plan Act’s marketplace provisions: early implementation experiences and lessons learned from three state-based marketplaces1
- The COVID-19 vaccine rollout: how the current vaccine environment could impact uptake among adults ages 50 and older1
- The Elijah E. Cummings Lower Drug Costs Now Act: how it would work, how it would affect prices, and what the challenges are1
- The English local government public health reforms: an independent assessment1
- The Families First Coronavirus Response Act: Medicaid and CHIP provisions explained1